The Centers for Medicare & Medicaid Services May 12 and May 14 will host calls for hospitals, health systems and providers on COVID-19. CMS will answer questions on temporary actions the agency has taken to increase hospital capacity; expand the health care workforce; and further promote telehealth.

Tuesday, May 12 call from 5-6 p.m. ET
Attendee Dial-in: 833-614-0820
Access Passcode: 8968295
Audio Webcast (You must register to participate in the audio webcast.)

Thursday, May 14 call from 5-6 p.m. ET
Attendee Dial-in: 833-614-0820
Access Passcode: 5688374
Audio Webcast (You must register to participate in the audio webcast.)

In addition, CMS May 15 will host a call with the Food and Drug Administration for physicians and clinical leaders on COVID-19. The call is an opportunity to hear physicians and other clinical leaders share their experiences, best practices and strategies, and insights related to COVID-19.

Friday, May 15 Call from 12:30-2 p.m. ET
Attendee Dial-in: 877-251-0301
Access Passcode: 8983296
Audio Webcast (You must register to participate in the audio webcast.)

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…